Equities

WDB coco Co Ltd

7079:TYO

WDB coco Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)3,730.00
  • Today's Change0.00 / 0.00%
  • Shares traded10.90k
  • 1 Year change-21.47%
  • Beta0.5203
Data delayed at least 20 minutes, as of Nov 11 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments2,6592,0021,889
Total Receivables, Net1,3641,024839
Total Inventory1.951.654.49
Prepaid expenses341925
Other current assets, total1.541.541.60
Total current assets4,0603,0482,759
Property, plant & equipment, net136131154
Goodwill, net134----
Intangibles, net1053114
Long term investments--238--
Note receivable - long term------
Other long term assets989494
Total assets4,6593,6613,134
LIABILITIES
Accounts payable777778
Accrued expenses256270235
Notes payable/short-term debt000
Current portion long-term debt/capital leases131111
Other current liabilities, total583362531
Total current liabilities929719855
Total long term debt141322
Total debt272434
Deferred income tax------
Minority interest------
Other liabilities, total153126108
Total liabilities1,095858986
SHAREHOLDERS EQUITY
Common stock280279276
Additional paid-in capital280279276
Retained earnings (accumulated deficit)3,0042,2451,597
Treasury stock - common(0.47)(0.47)(0.47)
Unrealized gain (loss)------
Other equity, total0.000.00--
Total equity3,5642,8032,148
Total liabilities & shareholders' equity4,6593,6613,134
Total common shares outstanding2.402.402.39
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.